Key Words:
Synthetic Carbohydrate Receptors, Formulations
This invention relates to the formulation of a bioactive compounds Synthetic Carbohydrate Receptors (SCRs) developed for use in in-vitro and in-vivo experimental studies. The formulation enhances the compound’s stability, solubility, and bioavailability, thereby improving its efficacy and usability in biological testing.
We anticipate that the formulations described herein could be used clinically.
Current standard methods and formulations suffer from limitations such as poor solubility, instability, or low bioavailability in biological systems. This invention addresses those limitations, enabling more effective clinical efficacy of the compound.
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"